Salivary Oxytocin Is Negatively Associated With Religious Faith in Japanese Non-Abrahamic People.

endogenous hormone non-Abrahamic religion religious faith salivary oxytocin spirituality/religiosity

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2021
Historique:
received: 06 05 2021
accepted: 03 08 2021
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 14 9 2021
Statut: epublish

Résumé

Spirituality and religiosity have a significant impact on one's well-being. Although previous studies have indicated that the neuropeptide hormone oxytocin is associated with spirituality/religiosity, existing findings remain inconsistent. Some studies have reported a positive relationship between oxytocin and spirituality/religiosity, while other studies have reported a negative association. Herein, we examined the association between endogenous oxytocin and spirituality/religiosity in 200 non-Abrahamic Japanese individuals (102 females, mean age ± standard deviation = 41.53 ± 10.46) by measuring the level of salivary oxytocin and spiritual/religious faith. We found that the level of salivary oxytocin was negatively associated with spiritual/religious faith. Individuals with higher levels of salivary oxytocin tend to have more negative spiritual/religious faith compared with those with low oxytocin levels (e.g., "

Identifiants

pubmed: 34512461
doi: 10.3389/fpsyg.2021.705781
pmc: PMC8427280
doi:

Types de publication

Journal Article

Langues

eng

Pagination

705781

Informations de copyright

Copyright © 2021 Yamada, Nakawake, Shou, Nishina, Matsunaga and Takagishi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2012;7(11):e46751
pubmed: 23144787
Psychophysiology. 2007 May;44(3):444-9
pubmed: 17371496
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1262-6
pubmed: 21220339
Ann N Y Acad Sci. 2007 Mar;1098:312-22
pubmed: 17435137
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6394-6399
pubmed: 28559334
Soc Cogn Affect Neurosci. 2016 Oct;11(10):1579-87
pubmed: 27317929
Science. 2015 Apr 17;348(6232):333-6
pubmed: 25883356
Horm Behav. 2017 Apr;90:64-74
pubmed: 28254475
Front Psychol. 2019 Jul 09;10:1525
pubmed: 31354566
Philos Trans R Soc Lond B Biol Sci. 2006 Dec 29;361(1476):2215-28
pubmed: 17118934
Sci Rep. 2017 Nov 7;7(1):14654
pubmed: 29116134
Psychol Sci. 2014 Sep;25(9):1699-711
pubmed: 25037961
Psychosom Med. 2011 Jun;73(5):393-400
pubmed: 21636661
Psychoneuroendocrinology. 2012 Aug;37(8):1277-85
pubmed: 22281209
Soc Cogn Affect Neurosci. 2018 Oct 25;13(10):1091-1097
pubmed: 30202991
Neuropsychopharmacology. 2013 Jun;38(7):1154-62
pubmed: 23325323
Int J Geriatr Psychiatry. 2017 Jan;32(1):102-109
pubmed: 26898770
J Genet Psychol. 2015;176(6):369-85
pubmed: 26287515
Proc Natl Acad Sci U S A. 2017 May 16;114(20):5300-5305
pubmed: 28461468
J Neurosci Methods. 2018 Jan 1;293:67-76
pubmed: 28865986
Psychoneuroendocrinology. 2015 Dec;62:381-8
pubmed: 26385109
PLoS One. 2016 Jul 14;11(7):e0158671
pubmed: 27414803
Neurosci Biobehav Rev. 2013 Sep;37(8):1485-92
pubmed: 23665533
Science. 2010 Jun 11;328(5984):1408-11
pubmed: 20538951
Elife. 2019 Jan 25;8:
pubmed: 30681410
Neurosci Biobehav Rev. 2017 Jul;78:117-124
pubmed: 28442403
Annu Rev Psychol. 2014;65:17-39
pubmed: 24050183
Dev Psychol. 2008 Mar;44(2):532-43
pubmed: 18331142
J Gerontol B Psychol Sci Soc Sci. 2002 Mar;57(2):S96-S107
pubmed: 11867670
Horm Behav. 2017 Jul;93:184-192
pubmed: 28576647
Neuroscience. 2010 Mar 10;166(1):168-77
pubmed: 20018229
J Neuroendocrinol. 2018 Apr 3;:e12596
pubmed: 29611254
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9085-90
pubmed: 24927552
Biol Psychiatry. 2016 Feb 1;79(3):194-202
pubmed: 26321019
Sci Rep. 2016 Jun 14;6:27824
pubmed: 27296466
CNS Neurosci Ther. 2008 Fall;14(3):165-70
pubmed: 18801109
Brain Res. 2014 Sep 11;1580:133-42
pubmed: 24184574
Biol Psychiatry. 2014 Aug 15;76(4):281-8
pubmed: 24183103
Hum Nat. 2005 Dec;16(4):410-46
pubmed: 26189839
Dev Psychobiol. 2009 May;51(4):367-73
pubmed: 19365797
Psychoneuroendocrinology. 2013 Sep;38(9):1883-94
pubmed: 23856187
Neuropsychopharmacology. 2015 Mar;40(4):966-73
pubmed: 25308350
Horm Behav. 2020 Jun;122:104733
pubmed: 32179059
Psychiatry Investig. 2018 Nov;15(11):1079-1086
pubmed: 30301300
Psychol Sci. 2012;23(11):1288-92
pubmed: 22991128
PLoS One. 2012;7(12):e50945
pubmed: 23251406
PLoS One. 2015 Oct 07;10(10):e0137089
pubmed: 26444016
Front Hum Neurosci. 2019 Jul 09;13:230
pubmed: 31354450
Horm Behav. 2012 Mar;61(3):380-91
pubmed: 22285934
Brain Res. 2014 Sep 11;1580:172-9
pubmed: 24055737
Elife. 2020 Dec 11;9:
pubmed: 33306025

Auteurs

Junko Yamada (J)

Brain Science Institute, Tamagawa University, Machida, Japan.

Yo Nakawake (Y)

Center for the Study of Social Cohesion, University of Oxford, Oxford, United Kingdom.
School of Economics & Management, Kochi University of Technology, Kami, Japan.

Qiulu Shou (Q)

Graduate School of Brain Sciences, Tamagawa University, Machida, Japan.

Kuniyuki Nishina (K)

Graduate School of Human Sciences, Osaka University, Suita, Japan.

Masahiro Matsunaga (M)

Department of Health and Psychosocial Medicine, Aichi Medical University, School of Medicine, Nagakute, Japan.

Haruto Takagishi (H)

Brain Science Institute, Tamagawa University, Machida, Japan.

Classifications MeSH